ES2102642T3 - Derivados azucares de macrolidos. - Google Patents

Derivados azucares de macrolidos.

Info

Publication number
ES2102642T3
ES2102642T3 ES93904534T ES93904534T ES2102642T3 ES 2102642 T3 ES2102642 T3 ES 2102642T3 ES 93904534 T ES93904534 T ES 93904534T ES 93904534 T ES93904534 T ES 93904534T ES 2102642 T3 ES2102642 T3 ES 2102642T3
Authority
ES
Spain
Prior art keywords
macrolides
group
sugar derivatives
macrolids
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93904534T
Other languages
English (en)
Inventor
Kevin Koch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Corp SRL
Original Assignee
Pfizer Corp Belgium
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Corp SRL filed Critical Pfizer Corp Belgium
Application granted granted Critical
Publication of ES2102642T3 publication Critical patent/ES2102642T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

MACROLIDOS DE FORMULA (I) Y METODOS DE TRATAMIENTO DE LA RESISTENCIA A LOS TRANSPLANTES, INFECCIONES FUNGICAS Y ENFERMEDADES AUTOINMUNES TALES COMO LA ARTRITIS REUMATOIDE Y LA PSORIASIS, USANDO LAS CITADAS MACROLIDOS DE FORMULA (I). DONDE N ES 1 O 2; A Y B SE TOMAN JUNTAMENTE Y FORMAN = O O A Y B SE TOMAN SEPARADAMENTE Y SON CADA UNO H O A ES OH Y B ES H; R1 ES UN GRUPO GLICOSILO; R2 ES OH O UN GRUPO GLICOSILOXI; Y R3 ES UN GRUPO ALQUILO O ALILO.
ES93904534T 1992-03-02 1993-01-28 Derivados azucares de macrolidos. Expired - Lifetime ES2102642T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84433192A 1992-03-02 1992-03-02

Publications (1)

Publication Number Publication Date
ES2102642T3 true ES2102642T3 (es) 1997-08-01

Family

ID=25292419

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93904534T Expired - Lifetime ES2102642T3 (es) 1992-03-02 1993-01-28 Derivados azucares de macrolidos.

Country Status (14)

Country Link
US (1) US5747465A (es)
EP (1) EP0629209B1 (es)
JP (1) JP2563080B2 (es)
AT (1) ATE153027T1 (es)
AU (1) AU3586293A (es)
CA (1) CA2131372C (es)
DE (1) DE69310721T2 (es)
DK (1) DK0629209T3 (es)
ES (1) ES2102642T3 (es)
FI (1) FI107535B (es)
GR (1) GR3024048T3 (es)
IL (1) IL104817A0 (es)
MX (1) MX9301060A (es)
WO (1) WO1993018050A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP584198A0 (en) * 1998-09-14 1998-10-08 Fujisawa Pharmaceutical Co., Ltd. New use
EP1768662A2 (en) 2004-06-24 2007-04-04 Novartis Vaccines and Diagnostics, Inc. Small molecule immunopotentiators and assays for their detection
JP2007519758A (ja) 2004-12-01 2007-07-19 テバ ジョジセルジャール ザ−トケルエン ムケド レ−スベニュタ−ルシャシャ−グ 結晶マクロライドの生成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1467383A (en) * 1974-06-12 1977-03-16 Farmaceutici Italia Daunomycin analogues
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
EP0346427B1 (en) * 1987-12-09 1995-03-29 FISONS plc Macrocyclic compounds
JPH05504944A (ja) * 1989-08-18 1993-07-29 藤沢薬品工業株式会社 巨大環式化合物
IE904050A1 (en) * 1989-11-13 1991-05-22 Merck & Co Inc Aminomacrolides and derivatives having immunosuppressive¹activity
EP0466365A3 (en) * 1990-07-03 1992-04-15 Merck & Co. Inc. Novel immunosuppressant fermentation products of a microorganism

Also Published As

Publication number Publication date
EP0629209A1 (en) 1994-12-21
IL104817A0 (en) 1993-06-10
CA2131372C (en) 1998-07-14
US5747465A (en) 1998-05-05
CA2131372A1 (en) 1993-09-16
ATE153027T1 (de) 1997-05-15
DE69310721D1 (de) 1997-06-19
AU3586293A (en) 1993-10-05
DK0629209T3 (da) 1997-10-13
JPH07500352A (ja) 1995-01-12
FI944017L (fi) 1994-09-01
JP2563080B2 (ja) 1996-12-11
MX9301060A (es) 1993-09-01
FI107535B (fi) 2001-08-31
EP0629209B1 (en) 1997-05-14
GR3024048T3 (en) 1997-10-31
DE69310721T2 (de) 1997-09-04
FI944017A0 (fi) 1994-09-01
WO1993018050A1 (en) 1993-09-16

Similar Documents

Publication Publication Date Title
NO20000762D0 (no) Anvendelse av substituerte adeninderivater til behandling av multippel sklerose
YU48323B (sh) Postupak za dobijanje askorbinske kiseline
ATE71627T1 (de) Bryostatine.
ES2160593T3 (es) Desosamino-derivados de microlidos como inmunosupresores y agentes antifungicos.
ES2102642T3 (es) Derivados azucares de macrolidos.
ES2052598T3 (es) Derivados de hetaril-oxi-beta-carbolinas, su preparacion y utilizacion como medicamentos.
FR2358150A1 (fr) Nouvelles thieno (2,3-c) et (3,2-c) pyridines, leur procede de preparation et leur application
JPS54119499A (en) Triazolobenzodiazepin derivative
AR217668A1 (es) Procedimiento de preparacion de derivados de tetrahidro-4,5,6,7-tieno-(2,3-c)-y-(3,2-c)-piridinas,utilizables como medicamentos
CA2132457A1 (en) Fluorosugar Derivatives of Macrolides
ES2108261T3 (es) Derivados 2-aminoazucar de macrolidos.
JPS5363379A (en) Preparation of 2-phenylbenzotriazoles or their n-oxides
EP0148953A4 (en) 7-FLUOROPROSTAGLANDINS AND THEIR PREPARATION PROCESS.
DE3876193D1 (de) Aminomethylderivate von mono- und dithiocarbamaten als schmiermitteladditive.
PT65040B (fr) Procede de preparation de derives de la tetrahydro-4,5,6,7thieno (3,2-c) pyridine
DE3662887D1 (en) Homocysteine thiolactone derivatives, process for the preparation thereof and pharmaceutical compositions therefrom
SE8504538L (sv) Karbapenem-antibiotika
ES2058580T3 (es) Nuevos beta-d-feniltioxilosidos, su metodo de preparacion y su uso como medicamentos.
FR2380277A1 (fr) L'antibiotique desacetyl, dihydro 890 a9
BE851180A (fr) Nouveaux derives de la thieno (3,2-c)pyridine
GB2011410A (en) Pyrido[1,2-a]Pyrimidine Derivatives, Their Preparation and Pharmaceutical Compositions Containing Them
ES379868A1 (es) Procedimiento para la obtencion de derivados basicamente sustituidos de la 1,2,3-benzotriazin-4 (3h)-ona.
JPS54141553A (en) Signal separation circuit
DE3990349T1 (de) Stereospezifisches verfahren zur herstellung von enantiomeren von furo(3,4-c)pyridin, so erhaltene verbindungen und therapeutische zusammensetzungen auf basis dieser verbindungen
FI853664A0 (fi) Erektion och fertilitet befraemjande medel, foerfarande foer framstaellning av detta och anvaendning av detta vid framstaellning av erektion och fertilitet befraemjande kompositioner.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 629209

Country of ref document: ES